KQ6-32670-43402 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-06
Dose 1 — Pfizer-BioNTech
2021-03-27
Dose 2 — Pfizer-BioNTech
2021-03-28
Registered in v-safe
2021-03-28
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-03-29
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-30
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-31
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-01
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache

Adult check-in
2021-04-02
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache

Adult check-in
2021-04-03
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-04-12
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-04-17
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-04-24
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-05-03
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-05-08
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-06-26
Survey response — 3 months, dose 2
MedDRA: Cough, Respiratory tract congestion — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Coughing and congestion

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-26
Report sent to call center — 3 months, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-29
Call 1 — Left Voicemail
2021-09-25
Survey response — 6 months, dose 2
MedDRA: Cough, Nasopharyngitis, Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Cold symptoms: congestion, runny nose, cough, sore throat.

MedDRA releases: 2024-11 · check-in free text available
2021-10-16
Dose 3 — Pfizer-BioNTech
2022-03-27
Survey response — 12 months, dose 2
MedDRA: Nasopharyngitis, Oropharyngeal pain, Rhinorrhoea — Feeling: Good

Free text: Just a cold: runny nose, sore throat.

MedDRA releases: 2024-11 · check-in free text available
2022-04-21
Survey response — 6 months, dose 3
MedDRA: Respiratory tract congestion, Rhinorrhoea, Sneezing — Feeling: Good · Be unable to work or attend school

Free text: Congestion, sneezing, runny nose

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-06	Pfizer-BioNTech
2	2021-03-27	Pfizer-BioNTech
3	2021-10-16	Pfizer-BioNTech	No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 9 — 3 months, dose 2

2021-06-26

Symptoms: Coughing and congestion

Release 9 — 6 months, dose 2

2021-09-25

Symptoms: Cold symptoms: congestion, runny nose, cough, sore throat.

Release 11 — 12 months, dose 2

2022-03-27

Symptoms: Just a cold: runny nose, sore throat.

Release 11 — 6 months, dose 3

2022-04-21

Symptoms: Congestion, sneezing, runny nose

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	✓	✓	✓
SD	Nasopharyngitis	·	·	✓
SD	Oropharyngeal pain	·	·	✓
SD	Respiratory tract congestion	✓	✓	✓
SD	Rhinorrhoea	·	·	✓
SD	Sneezing	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release